ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Patrick J Heron bought $119K of Arcutis Biotherapeutics, Inc.
Bought$119,352
$13.76Price
8,674Shares
What ARQT did for a copier
- $1,000 copied at Fri, May 16 open, $13.79
- $997
- S&P 500, same days
- +4.8%
Measured over 30 trading days, to the Jul 1 close.
Patrick J Heron's record
15 other buys with 3 months of prices since 2020: on average +5.4% against the S&P 500, and 9 of 15 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, May 13. Filed Thu, May 15, 4:18 PM ET, after the close. Returns use the May 16 open and the Jul 1 close. Not investment advice.